Get the full picture
Sign in to uncover key details.
Show More
CRISPR Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Baarerstrasse 14, Zug, Zug, 6300, Switze...Phone Number
+41 415613277Website
www.crisprtx.comRevenue
$11 MillionStock Symbol
CRSPIndustry
About CRISPR Therapeutics
CRISPR Therapeutics is a biotechnology company headquartered in Zug, Switzerland, with additional operations in Boston, San Francisco, and London. Founded in 2013, the company pioneers CRISPR/Cas9 gene-editing technology to develop transformative medicines for serious diseases, including sickle cell disease, beta thalassemia, various cancers, diabetes, and cardiovascular conditions. It co-developed Casgevy, the first approved CRISPR-based therapy, in collaboration with Vertex Pharmaceuticals, and maintains strategic partnerships with leading biopharma organizations to advance its diverse therapeutic pipeline.Explore more
CRISPR Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
CRISPR Therapeutics Tech Stack
A closer look at the technologies used by CRISPR Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CRISPR Therapeutics
Sign Up For FreeTo access detailed company insights
CRISPR Therapeutics is a biotechnology company headquartered in Zug, Switzerland, with additional operations in Boston, San Francisco, and London. Founded in 2013, the company pioneers CRISPR/Cas9 gene-editing technology to develop transformative medicines for serious diseases, including sickle cell disease, beta thalassemia, various cancers, diabe... Read More
